The NeuroNEXT Network consists of a Clinical Coordinating Center (CCC) at Massachusetts General Hospital, a Data Coordinating Center (DCC) at the University of Iowa, and 25 clinical sites throughout the country. Since 2011, we have been working together to improve productivity and expedite therapy development for neurological disorders. Features of the Network, including a Central IRB and a standardized Master Trial Agreement, are designed to efficiently conduct Phase II Clinical Trials. Studies in the Network are expected to take advantage of the experienced CCC and DCC, who work with investigators through the life-cycle of their project, as well as the well-trained clinical sites located throughout the US. Our funding comes from the National Institute of Neurological Disorders and Stroke (NINDS), and we work closely with NINDS representatives in all of our undertakings.
Get to know our groups at the links to the right. If you are interested in submitting a project, please visit our grant application page.
